Rockwell Medical Receives Canadian Patent for SFP Formulation for Iron-Delivery in Hemodialysis Patients

by Benzinga Staff
August 28, 2012 7:30 AM | 20 seconds read | Make a Comment

Crypto Whales Are Loading Up — Are You?

New research shows the biggest crypto buyers are back. And this time? They could hold for the possibility that Bitcoin will surpass $100,000 in 2024. You don’t want to miss the next massive crypto bull run like we saw in 2020 and 2021. To know exactly what’s going on and what to buy… Get Access To Benzinga’s Best Crypto Research and Investments For Only $1.

Rockwell Medical (NASDAQ: RMTI), a fully-integrated biopharmaceutical company targetingend-stage renal disease (ESRD) and chronic kidney disease (CKD) withinnovative products for the treatment of iron deficiency, secondaryhyperparathyroidism and hemodialysis, announced today that it hasreceived notice from the Canadian Intellectual Property Office thatit has obtained patent issuance for its proprietary GMP formulationfor Soluble Ferric Pyrophosphate (SFP), the Company's leadinvestigational drug that provides iron replacement to hemodialysispatients with CKD.

Crypto Whales Are Loading Up — Are You?

New research shows the biggest crypto buyers are back. And this time? They could hold for the possibility that Bitcoin will surpass $100,000 in 2024. You don’t want to miss the next massive crypto bull run like we saw in 2020 and 2021. To know exactly what’s going on and what to buy… Get Access To Benzinga’s Best Crypto Research and Investments For Only $1.

ENTER TO WIN $500 IN STOCK OR CRYPTO

Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!

Posted In: NewsLegal

© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.